Veru to present at the oppenheimer 33rd annual healthcare conference

Miami, fl., march 07, 2023 (globe newswire) -- veru inc. (nasdaq: veru), a biopharmaceutical company focused on developing novel medicines for covid-19 and other viral ards-related diseases and for oncology, today announced that mitchell steiner, m.d., chairman, president and chief executive officer of veru, will present at the upcoming virtual oppenheimer 33rd annual healthcare conference on tuesday, march 14, 2023 at 12 pm et.
VERU Ratings Summary
VERU Quant Ranking